Pharmacyclics (PCYC) Tops Q3 EPS by 32c
Get Alerts PCYC Hot Sheet
Price: $261.25 --0%
Financial Fact:
Loss from operations: 3.78M
Today's EPS Names:
SHIM, KOD, HEWA, More
Financial Fact:
Loss from operations: 3.78M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Pharmacyclics (NASDAQ: PCYC) reported Q3 EPS of $0.69, $0.32 better than the analyst estimate of $0.37. Revenue for the quarter came in at $307 million versus the consensus estimate of $201.5 million.
For earnings history and earnings-related data on Pharmacyclics (PCYC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RH touts 'exceptional' demand for new collections after Q4 results fall short
- RBC lifts S&P 500 target to 5,300, adjusts EPS forecast
- Celcuity (CELC) Tops Q4 EPS by 16c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!